OTCQB: LXXGF | TSX.V: LXG
Cleanroom Technology Feb. 22 article: we will explore a handful of common bioreactors and cleanroom organisms in terms of why they are able to proliferate and persist despite thorough Quality by Design (QbD) developed methods of production.
Dr. Jack Regan, CEO and Founder of LexaGene gives an update to BioPub Investment group on January 26, 2021.
Dr. Jack Regan, CEO of LexaGene, shares his work identifying the future biothreats human and veterinary populations may face.
GenomeWeb picked up our announcement and reports on LexaGene’s cooperative research agreement with the US Army.
In the latest issue of the Pathologist, Dr. Jack Regan discusses the strategic priorities and technologies that could prevent the next global pandemic: